Palti Yoram 4
4 · NovoCure Ltd · Filed Aug 28, 2018
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Palti Yoram
DirectorChief Technology Officer
Transactions
- Sale
Ordinary Shares
2018-08-27$40.05/sh−13,450$538,663→ 1,045,388 total(indirect: Bennett Limited) - Sale
Ordinary Shares
2018-08-24$40.00/sh−12,216$488,645→ 1,058,838 total(indirect: Bennett Limited)
Footnotes (3)
- [F1]On August 24, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 12,216 shares in multiple trades at prices ranging from $40.00 to $40.05. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]Professor Palti shares voting and investment power for the shares held by Bennett Limited.
- [F3]On August 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 13,450 shares in multiple trades at prices ranging from $40.00 to $40.35. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.